Mohamed Elmeliegy, n/a

Oncology Research and Development
Pfizer Inc

Poster(s):

• (PA-045) Elranatamab Fixed Dosing: The Optimal Dosing Strategy for Safety, Efficacy, and Convenience Across Body Weights
  Wednesday, September 17, 2025